Physician profile
Lali Levi
NPI 1962508184
$873.69
in general payments reported to CMS, 2019-2025
12 companies · $89.90 in 2025
The $89.90 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $55.79 · 2021: $16.64 · 2022: $108 · 2023: $245 · 2024: $172 · 2025: $89.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $198.29 | 2019-2024 | Xarelto |
| Pfizer INC. | $158.68 | 2019-2025 | |
| Alkermes, INC. | $116.99 | 2023 | Lybalvi |
| Novartis Pharmaceuticals Corporation | $109.56 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $67.16 | 2022-2024 | Eliquis |
| Abbvie INC. | $52.14 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.00 | 2025 | Lifevest |
| Mallinckrodt Hospital Products INC. | $34.10 | 2024 | Terlivaz |
| Kestra Medical Technology Services, INC. | $28.39 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.69 | 2022 | |
| Amgen INC. | $20.58 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lali Levi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.